Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis ... that primary ...

Multiple sclerosis (MS) is a common immune-mediated ... primary progressive, and progressive relapsing MS. A clinically isolated syndrome (CIS) is a first neurological episode lasting more than ...

Avonex® IFN-β-1a im. weekly RRMS and 'early therapy' in patients with an initial demyelinating event and high risk of occurrence of clinically definite MS Rebif® IFN-β-1a sc. three times a ...

So we'll go online, and I'll see this relapsing, remitting, and primary progressive and secondary progression. All of those names were derived when we didn't really understand the disease as much ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Multiple sclerosis (MS ... and about 2.9 million people worldwide. There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t ...

Let's talk about how multiple sclerosis impacts cognitive function ... which occurs in both relapsing MS and in the progressive forms of MS can perpetuate depression, and that brain fog, slowing ...

People with multiple sclerosis (MS ... new symptoms occurring either in discrete attacks (relapsing forms) or slowly accumulating over time (progressive forms). Between attacks, symptoms may ...

Multiple Sclerosis (MS) is an autoimmune ... Progressive MS: Previously, progressive forms of MS were divided into Secondary Progressive – arising from prior Relapsing MS – and Primary Progressive – ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS) Tolebrutinib is the first and only brain-penetrant ...